Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 177

Similar articles for PubMed (Select 23546450)

1.

miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling.

Chen Y, Sun Y, Chen L, Xu X, Zhang X, Wang B, Min L, Liu W.

Mol Med Rep. 2013 May;7(5):1579-84. doi: 10.3892/mmr.2013.1403. Epub 2013 Mar 28.

PMID:
23546450
2.
3.

Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells.

Manavalan TT, Teng Y, Litchfield LM, Muluhngwi P, Al-Rayyan N, Klinge CM.

PLoS One. 2013 Apr 23;8(4):e62334. doi: 10.1371/journal.pone.0062334. Print 2013.

4.

MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

Zhong S, Li W, Chen Z, Xu J, Zhao J.

Gene. 2013 Nov 15;531(1):8-14. doi: 10.1016/j.gene.2013.08.062. Epub 2013 Aug 29.

PMID:
23994196
5.

MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.

Bai WD, Ye XM, Zhang MY, Zhu HY, Xi WJ, Huang X, Zhao J, Gu B, Zheng GX, Yang AG, Jia LT.

Int J Cancer. 2014 Sep 15;135(6):1356-68. doi: 10.1002/ijc.28782. Epub 2014 Mar 3.

PMID:
24615544
6.

MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.

Wang ZX, Lu BB, Wang H, Cheng ZX, Yin YM.

Arch Med Res. 2011 May;42(4):281-90. doi: 10.1016/j.arcmed.2011.06.008.

PMID:
21820606
7.

Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.

Steelman LS, Navolanic PM, Sokolosky ML, Taylor JR, Lehmann BD, Chappell WH, Abrams SL, Wong EW, Stadelman KM, Terrian DM, Leslie NR, Martelli AM, Stivala F, Libra M, Franklin RA, McCubrey JA.

Oncogene. 2008 Jul 3;27(29):4086-95. doi: 10.1038/onc.2008.49. Epub 2008 Mar 10.

8.

Targets of miR-200c mediate suppression of cell motility and anoikis resistance.

Howe EN, Cochrane DR, Richer JK.

Breast Cancer Res. 2011 Apr 18;13(2):R45. doi: 10.1186/bcr2867.

9.

Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.

Kim MR, Choi HK, Cho KB, Kim HS, Kang KW.

Cancer Sci. 2009 Oct;100(10):1834-41. doi: 10.1111/j.1349-7006.2009.01260.x. Epub 2009 Jul 24.

PMID:
19681904
10.

Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.

Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, Zhao L, Qu H, Fan Y, Wu C.

PLoS One. 2012;7(6):e39520. doi: 10.1371/journal.pone.0039520. Epub 2012 Jun 25.

11.

A marine anthraquinone SZ-685C overrides adriamycin-resistance in breast cancer cells through suppressing Akt signaling.

Zhu X, He Z, Wu J, Yuan J, Wen W, Hu Y, Jiang Y, Lin C, Zhang Q, Lin M, Zhang H, Yang W, Chen H, Zhong L, She Z, Chen S, Lin Y, Li M.

Mar Drugs. 2012 Apr;10(4):694-711. doi: 10.3390/md10040694. Epub 2012 Mar 23.

12.

Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.

Lindberg K, Helguero LA, Omoto Y, Gustafsson JÅ, Haldosén LA.

Breast Cancer Res. 2011 Apr 14;13(2):R43. doi: 10.1186/bcr2865.

13.
14.

microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.

Wang X, Chen X, Wang R, Xiao P, Xu Z, Chen L, Hang W, Ruan A, Yang H, Zhang X.

Oncol Rep. 2013 Aug;30(2):643-50. doi: 10.3892/or.2013.2530. Epub 2013 Jun 7.

PMID:
23754305
15.

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, Pogribny IP.

Mol Cancer Ther. 2008 Jul;7(7):2152-9. doi: 10.1158/1535-7163.MCT-08-0021.

16.

Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells.

Steelman LS, Navolanic P, Chappell WH, Abrams SL, Wong EW, Martelli AM, Cocco L, Stivala F, Libra M, Nicoletti F, Drobot LB, Franklin RA, McCubrey JA.

Cell Cycle. 2011 Sep 1;10(17):3003-15. Epub 2011 Sep 1.

17.

Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.

Cong N, Du P, Zhang A, Shen F, Su J, Pu P, Wang T, Zjang J, Kang C, Zhang Q.

Oncol Rep. 2013 Apr;29(4):1579-87. doi: 10.3892/or.2013.2267. Epub 2013 Jan 31.

PMID:
23381389
18.

[Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR].

Cui XY, Guo YJ, Yao HR.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Oct;28(10):1813-5. Chinese.

19.

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.

Adv Enzyme Regul. 2006;46:249-79. Epub 2006 Jul 18.

PMID:
16854453
20.

The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.

Kang Y, Park MA, Heo SW, Park SY, Kang KW, Park PH, Kim JA.

Biochim Biophys Acta. 2013 Mar;1830(3):2638-48.

PMID:
23246576
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk